ESC 365 - Current pharmacological treatment of heart failure with mid-range ejection fraction - discussion.

Open Access

Current pharmacological treatment of heart failure with mid-range ejection fraction - discussion.

Session: Current pharmacological treatment of heart failure with mid-range ejection fraction

Topic: Chronic Heart Failure

Event: Heart Failure 2021 Online Congress

Congress Session

3 more presentations in this session

What is the evidence and which beta-blocker should a patient with HFmrEF receive?

Speaker: Professor A. Coats (Coventry, GB)

What is the evidence and which aldosterone antagonist should a patient with HFmrEF receive?

Speaker: Professor F. Martinez (Cordoba, AR)

What other pharmacological treatments should a patient with HFmrEF receive?

Speaker: Professor L. Lund (Stockholm, SE)

Access the full session

Current pharmacological treatment of heart failure with mid-range ejection fraction

Speakers: Professor A. Coats, Professor F. Martinez, Professor L. Lund

About the event

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Congress

Related content

Open Access

Pathophysiology and evolving definition of cardiogenic shock.

19 March 2022

Open Access

Medical treatment depends on etiology!

18 March 2022

Open Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: case presentation.

27 August 2021

This platform is supported by